LONGEVERON INC-A (LGVN) Fundamental Analysis & Valuation

NASDAQ:LGVN • US54303L2034

Current stock price

0.9 USD
-0.04 (-4.26%)
At close:
0.905 USD
+0.01 (+0.56%)
After Hours:

This LGVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. LGVN Profitability Analysis

1.1 Basic Checks

  • LGVN had negative earnings in the past year.
  • LGVN had a negative operating cash flow in the past year.
  • In the past 5 years LGVN always reported negative net income.
  • In the past 5 years LGVN always reported negative operating cash flow.
LGVN Yearly Net Income VS EBIT VS OCF VS FCFLGVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • LGVN's Return On Assets of -221.26% is on the low side compared to the rest of the industry. LGVN is outperformed by 90.10% of its industry peers.
  • LGVN's Return On Equity of -400.07% is on the low side compared to the rest of the industry. LGVN is outperformed by 76.89% of its industry peers.
Industry RankSector Rank
ROA -221.26%
ROE -400.07%
ROIC N/A
ROA(3y)-167.17%
ROA(5y)-122.01%
ROE(3y)-280.69%
ROE(5y)-195.89%
ROIC(3y)N/A
ROIC(5y)N/A
LGVN Yearly ROA, ROE, ROICLGVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • With a decent Gross Margin value of 66.97%, LGVN is doing good in the industry, outperforming 78.45% of the companies in the same industry.
  • LGVN's Gross Margin has improved in the last couple of years.
  • LGVN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.09%
GM growth 5Y15.6%
LGVN Yearly Profit, Operating, Gross MarginsLGVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. LGVN Health Analysis

2.1 Basic Checks

  • LGVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LGVN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, LGVN has more shares outstanding
  • There is no outstanding debt for LGVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LGVN Yearly Shares OutstandingLGVN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
LGVN Yearly Total Debt VS Total AssetsLGVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -21.66, we must say that LGVN is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of LGVN (-21.66) is worse than 85.05% of its industry peers.
  • There is no outstanding debt for LGVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -21.66
ROIC/WACCN/A
WACC9.41%
LGVN Yearly LT Debt VS Equity VS FCFLGVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.33 indicates that LGVN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.33, LGVN is doing worse than 84.47% of the companies in the same industry.
  • LGVN has a Quick Ratio of 1.33. This is a normal value and indicates that LGVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LGVN's Quick ratio of 1.33 is on the low side compared to the rest of the industry. LGVN is outperformed by 83.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
LGVN Yearly Current Assets VS Current LiabilitesLGVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. LGVN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 69.36% over the past year.
  • LGVN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -49.87%.
  • The Revenue for LGVN have been decreasing by -26.60% on average. This is quite bad
EPS 1Y (TTM)69.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.51%
Revenue 1Y (TTM)-49.87%
Revenue growth 3Y-0.63%
Revenue growth 5Y-26.6%
Sales Q2Q%-39.47%

3.2 Future

  • Based on estimates for the next years, LGVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.70% on average per year.
  • The Revenue is expected to grow by 42.85% on average over the next years. This is a very strong growth
EPS Next Y51.37%
EPS Next 2Y22.87%
EPS Next 3Y9.7%
EPS Next 5YN/A
Revenue Next Year-24.99%
Revenue Next 2Y-8.83%
Revenue Next 3Y42.85%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LGVN Yearly Revenue VS EstimatesLGVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1M 2M 3M 4M 5M
LGVN Yearly EPS VS EstimatesLGVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6 -8 -10

More info and screens

Find the best growth stocksShow best growing peers

0

4. LGVN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LGVN. In the last year negative earnings were reported.
  • Also next year LGVN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGVN Price Earnings VS Forward Price EarningsLGVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LGVN Per share dataLGVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.87%
EPS Next 3Y9.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LGVN Dividend Analysis

5.1 Amount

  • No dividends for LGVN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LGVN Fundamentals: All Metrics, Ratios and Statistics

LONGEVERON INC-A

NASDAQ:LGVN (4/27/2026, 8:00:03 PM)

After market: 0.905 +0.01 (+0.56%)

0.9

-0.04 (-4.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-17
Earnings (Next)05-08
Inst Owners6.12%
Inst Owner Change0.96%
Ins Owners7.05%
Ins Owner Change-0.86%
Market Cap26.35M
Revenue(TTM)1.20M
Net Income(TTM)-22.70M
Analysts82.5
Price Target6.74 (648.89%)
Short Float %9.35%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.14%
Min EPS beat(2)-49.94%
Max EPS beat(2)45.67%
EPS beat(4)2
Avg EPS beat(4)0.54%
Min EPS beat(4)-49.94%
Max EPS beat(4)45.67%
EPS beat(8)4
Avg EPS beat(8)-10.25%
EPS beat(12)4
Avg EPS beat(12)-10.89%
EPS beat(16)5
Avg EPS beat(16)-9.63%
Revenue beat(2)1
Avg Revenue beat(2)44.48%
Min Revenue beat(2)-52.82%
Max Revenue beat(2)141.79%
Revenue beat(4)1
Avg Revenue beat(4)6.22%
Min Revenue beat(4)-52.82%
Max Revenue beat(4)141.79%
Revenue beat(8)3
Avg Revenue beat(8)167.38%
Revenue beat(12)3
Avg Revenue beat(12)98.86%
Revenue beat(16)6
Avg Revenue beat(16)82.46%
PT rev (1m)-3.64%
PT rev (3m)-3.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)31.25%
EPS NY rev (1m)53.23%
EPS NY rev (3m)53.23%
Revenue NQ rev (1m)10.22%
Revenue NQ rev (3m)50%
Revenue NY rev (1m)-14.92%
Revenue NY rev (3m)7.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.98
P/FCF N/A
P/OCF N/A
P/B 4.64
P/tB 7.77
EV/EBITDA N/A
EPS(TTM)-1.29
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0.04
BVpS0.19
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -221.26%
ROE -400.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.97%
FCFM N/A
ROA(3y)-167.17%
ROA(5y)-122.01%
ROE(3y)-280.69%
ROE(5y)-195.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.09%
GM growth 5Y15.6%
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.53%
Cap/Sales 49.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z -21.66
F-Score3
WACC9.41%
ROIC/WACCN/A
Cap/Depr(3y)75.15%
Cap/Depr(5y)92.93%
Cap/Sales(3y)62.99%
Cap/Sales(5y)71.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.51%
EPS Next Y51.37%
EPS Next 2Y22.87%
EPS Next 3Y9.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-49.87%
Revenue growth 3Y-0.63%
Revenue growth 5Y-26.6%
Sales Q2Q%-39.47%
Revenue Next Year-24.99%
Revenue Next 2Y-8.83%
Revenue Next 3Y42.85%
Revenue Next 5YN/A
EBIT growth 1Y-40.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.45%
OCF growth 3YN/A
OCF growth 5YN/A

LONGEVERON INC-A / LGVN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LONGEVERON INC-A (LGVN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to LGVN.


What is the valuation status of LONGEVERON INC-A (LGVN) stock?

ChartMill assigns a valuation rating of 0 / 10 to LONGEVERON INC-A (LGVN). This can be considered as Overvalued.


Can you provide the profitability details for LONGEVERON INC-A?

LONGEVERON INC-A (LGVN) has a profitability rating of 1 / 10.


Can you provide the financial health for LGVN stock?

The financial health rating of LONGEVERON INC-A (LGVN) is 5 / 10.


Can you provide the expected EPS growth for LGVN stock?

The Earnings per Share (EPS) of LONGEVERON INC-A (LGVN) is expected to grow by 51.37% in the next year.